Global Cancer News

PSMA PET-CT Accurately Detects Prostate Cancer Spread, Trial Shows


Traditionally, the most commonly used method of prostate cancer imaging is the CT scan or bone scan. The new use of PSMA PET-CT proved to be substantially more likely to detect metastatic tumors in men with prostate cancer than the standard imaging approach. The FDA hasn’t approached any PSMA-targeted imaging agents, so PSMA PET-CT isn’t available in the US outside of clinical studies yet.

For more information: